No Data
Guobang Pharmaceutical: Guobang Pharmaceutical 2024 Annual Report
Guobang Pharmaceutical: Summary of Guobang Pharmaceutical\'s 2024 Annual Report
Guobang Pharmaceutical 2024 Annual Report
Summary of Guobang Pharmaceutical\'s 2024 Annual Report
Guobang Pharmaceutical (605507.SH): plans to buy back shares for 0.1 billion to -0.2 billion yuan.
Gelonghui, March 10丨Guobang Pharmaceutical (605507.SH) announced that it plans to repurchase shares for an amount not less than 0.1 billion yuan and not more than 0.2 billion yuan, with a repurchase price not exceeding 25 yuan per share, for the employee stock ownership plan or Stock-based Incentive.
Guobang Pharma Ltd.'s (SHSE:605507) Stock Price Dropped 4.0% Last Week; Private Companies Would Not Be Happy
Guobang Pharma Ltd.'s (SHSE:605507) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
